{ "meta": { "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.", "terms": "https://open.fda.gov/terms/", "license": "https://open.fda.gov/license/", "last_updated": "2026-05-19", "results": { "skip": 0, "limit": 1, "total": 1 } }, "results": [ { "submissions": [ { "submission_type": "SUPPL", "submission_number": "21", "submission_status": "AP", "submission_status_date": "20150624", "review_priority": "STANDARD", "submission_class_code": "MANUF (CMC)", "submission_class_code_description": "Manufacturing (CMC)" }, { "submission_type": "SUPPL", "submission_number": "28", "submission_status": "AP", "submission_status_date": "20240508", "review_priority": "STANDARD", "submission_class_code": "LABELING", "submission_class_code_description": "Labeling", "application_docs": [ { "id": "78443", "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2024/022083Orig1s028ltr.pdf", "date": "20240509", "type": "Letter" }, { "id": "78457", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2024/022083s028lbl.pdf", "date": "20240514", "type": "Label" } ] }, { "submission_type": "SUPPL", "submission_number": "26", "submission_status": "AP", "submission_status_date": "20181218", "review_priority": "STANDARD", "submission_class_code": "LABELING", "submission_class_code_description": "Labeling", "application_docs": [ { "id": "56798", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022083s026lbl.pdf", "date": "20181219", "type": "Label" }, { "id": "56933", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2018/022083Orig1s026ltr.pdf", "date": "20181221", "type": "Letter" } ] }, { "submission_type": "SUPPL", "submission_number": "18", "submission_status": "AP", "submission_status_date": "20130313", "review_priority": "STANDARD", "submission_class_code": "MANUF (CMC)", "submission_class_code_description": "Manufacturing (CMC)" }, { "submission_type": "SUPPL", "submission_number": "16", "submission_status": "AP", "submission_status_date": "20120831", "review_priority": "STANDARD", "submission_class_code": "EFFICACY", "submission_class_code_description": "Efficacy", "application_docs": [ { "id": "45790", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2012/022083Orig1s016.pdf", "date": "20161102", "type": "Review" }, { "id": "6850", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2012/022083Orig1s016ltr.pdf", "date": "20120905", "type": "Letter" }, { "id": "16918", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/022083s016lbl.pdf", "date": "20120906", "type": "Label" } ] }, { "submission_type": "SUPPL", "submission_number": "20", "submission_status": "AP", "submission_status_date": "20150203", "review_priority": "STANDARD", "submission_class_code": "LABELING", "submission_class_code_description": "Labeling", "application_docs": [ { "id": "16919", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/022083s020lbl.pdf", "date": "20150205", "type": "Label" }, { "id": "29221", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/022083Orig1s020ltr.pdf", "date": "20150205", "type": "Letter" } ] }, { "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20070706", "review_priority": "STANDARD", "submission_class_code": "TYPE 3", "submission_class_code_description": "Type 3 - New Dosage Form", "application_docs": [ { "id": "42410", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2007/022083_exelon_toc.html", "date": "20090528", "type": "Review" }, { "id": "16916", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2007/022083lbl.pdf", "date": "20070709", "type": "Label" } ] }, { "submission_type": "SUPPL", "submission_number": "8", "submission_status": "AP", "submission_status_date": "20100827", "review_priority": "UNKNOWN", "submission_class_code": "LABELING", "submission_class_code_description": "Labeling", "application_docs": [ { "id": "6849", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2010/022083s008ltr.pdf", "date": "20100831", "type": "Letter" }, { "id": "16917", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/022083s008lbl.pdf", "date": "20100907", "type": "Label" } ] }, { "submission_type": "SUPPL", "submission_number": "19", "submission_status": "AP", "submission_status_date": "20130627", "review_priority": "STANDARD", "submission_class_code": "EFFICACY", "submission_class_code_description": "Efficacy", "application_docs": [ { "id": "38206", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022083s019lbl.pdf", "date": "20130711", "type": "Label" }, { "id": "6851", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2013/022083Orig1s019ltr.pdf", "date": "20130701", "type": "Letter" } ] }, { "submission_type": "SUPPL", "submission_number": "23", "submission_status": "AP", "submission_status_date": "20161102", "review_priority": "STANDARD", "submission_class_code": "LABELING", "submission_class_code_description": "Labeling", "application_docs": [ { "id": "45801", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2016/020823s035,021025s023,022083s023ltr.pdf", "date": "20161103", "type": "Letter" }, { "id": "45806", "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/022083s023lbl.pdf", "date": "20161104", "type": "Label" } ] } ], "application_number": "NDA022083", "sponsor_name": "SANDOZ", "openfda": { "application_number": [ "NDA022083" ], "brand_name": [ "RIVASTIGMINE", "EXELON" ], "generic_name": [ "RIVASTIGMINE" ], "manufacturer_name": [ "Sandoz Inc", "Novartis Pharmaceuticals Corporation" ], "product_ndc": [ "0781-7304", "0781-7309", "0781-7313", "0078-0501", "0078-0502", "0078-0503", "66758-142", "66758-143", "66758-144" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "TRANSDERMAL" ], "substance_name": [ "RIVASTIGMINE" ], "rxcui": [ "725021", "725023", "1308569", "725105", "751302", "1308571" ], "spl_id": [ "3a8271f5-aade-457e-8016-ef0f73c38f78", "9b5555ca-d9a2-4f50-8037-abbf702d0a27", "b6ed6d15-116d-4596-92ce-3414574d7ba0" ], "spl_set_id": [ "92a58ebb-748d-49f4-bf11-ecbcf5424152", "07c12e14-bbd5-4ec8-84e4-fbe7b5ba10e0", "b6ed6d15-116d-4596-92ce-3414574d7ba0" ], "package_ndc": [ "0781-7304-58", "0781-7304-31", "0781-7309-58", "0781-7309-31", "0781-7313-58", "0781-7313-31", "0078-0501-61", "0078-0501-15", "0078-0502-61", "0078-0502-15", "0078-0503-61", "0078-0503-15", "66758-142-58", "66758-142-31", "66758-143-58", "66758-143-31", "66758-144-58", "66758-144-31" ], "nui": [ "N0000175723", "N0000000177" ], "pharm_class_epc": [ "Cholinesterase Inhibitor [EPC]" ], "pharm_class_moa": [ "Cholinesterase Inhibitors [MoA]" ], "unii": [ "PKI06M3IW0" ] }, "products": [ { "product_number": "002", "reference_drug": "Yes", "brand_name": "EXELON", "active_ingredients": [ { "name": "RIVASTIGMINE", "strength": "9.5MG/24HR" } ], "reference_standard": "Yes", "dosage_form": "FILM, EXTENDED RELEASE", "route": "TRANSDERMAL", "marketing_status": "Prescription", "te_code": "AB" }, { "product_number": "005", "reference_drug": "Yes", "brand_name": "EXELON", "active_ingredients": [ { "name": "RIVASTIGMINE", "strength": "13.3MG/24HR" } ], "reference_standard": "No", "dosage_form": "FILM, EXTENDED RELEASE", "route": "TRANSDERMAL", "marketing_status": "Prescription", "te_code": "AB" }, { "product_number": "001", "reference_drug": "Yes", "brand_name": "EXELON", "active_ingredients": [ { "name": "RIVASTIGMINE", "strength": "4.6MG/24HR" } ], "reference_standard": "No", "dosage_form": "FILM, EXTENDED RELEASE", "route": "TRANSDERMAL", "marketing_status": "Prescription", "te_code": "AB" } ] } ] }